Indeed, co-cultivation of prostate cancer cells with skeletal or smooth muscle cells developed cancer hybrids with some CS/IC characteristics, such as an anchorage-independent growth, elevated CD133 expression, and drug resistance to doxorubicin and cisplatin [33]. The gene discussed is PROM1; the disease is cancer.